Abingworth

Abingworth as of March 31, 2011

Portfolio Holdings for Abingworth

Abingworth holds 27 positions in its portfolio as reported in the March 2011 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Amarin Corporation 45.0 $88M 12M 7.30
Alnylam Pharmaceuticals (ALNY) 8.8 $17M 1.8M 9.56
Incyte Corporation (INCY) 6.7 $13M 830k 15.84
Zogenix 5.9 $12M 2.3M 4.98
Micromet 4.8 $9.4M 1.7M 5.60
OncoGenex Pharmaceuticals 3.5 $6.8M 448k 15.25
Nektar Therapeutics (NKTR) 3.2 $6.3M 664k 9.46
Celgene Corporation 2.7 $5.2M 91k 57.53
Alexza Pharmaceuticals 2.5 $4.8M 2.9M 1.69
NPS Pharmaceuticals 2.4 $4.8M 498k 9.57
Exelixis (EXEL) 2.4 $4.7M 415k 11.29
Caliper Life Sciences 2.2 $4.2M 628k 6.76
Novavax 2.0 $3.9M 1.5M 2.59
ISIS Pharmaceuticals 1.2 $2.4M 268k 9.03
Zalicus 1.1 $2.1M 864k 2.43
Cardiome Pharma Corp 1.1 $2.1M 481k 4.27
Medicines Company 0.9 $1.7M 107k 16.28
Celldex Therapeutics 0.7 $1.4M 343k 4.02
Affymetrix 0.7 $1.3M 246k 5.20
Isis Pharmaceuticals Inc Del note 2.625% 2/1 0.6 $1.2M 1.3k 960.16
Allos Therapeutics 0.4 $837k 265k 3.16
Trimeris 0.4 $794k 320k 2.48
Cornerstone Therapeutics 0.3 $561k 85k 6.62
AVANIR Pharmaceuticals 0.2 $458k 113k 4.07
EntreMed 0.2 $362k 71k 5.12
Sunesis Pharmaceuticals 0.1 $248k 129k 1.92
Poniard Pharmaceuticals (PARD) 0.0 $77k 182k 0.42